23andMe snags 3rd FDA nod for cancer risk test, this time for prostate cancer
23andMe’s genetic analysis can connect people with long-lost family members, teach them about how their DNA can affect their health and lifestyle choices and, now, determine their hereditary risk of contracting prostate cancer.